• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎谱系障碍中的疼痛

Pain in neuromyelitis optic spectrum disorder.

作者信息

Xue Huiru, Yang Wen, Zhao Yunfei, Wang Li, Wang Guilian, Zhang Meini, Zhang Hui

机构信息

First Hospital of Shanxi Medical University, Taiyuan, Shanxi province, China.

First Hospital of Shanxi Medical University, Taiyuan, Shanxi province, China.

出版信息

Mult Scler Relat Disord. 2022 Dec;68:104192. doi: 10.1016/j.msard.2022.104192. Epub 2022 Sep 23.

DOI:10.1016/j.msard.2022.104192
PMID:36244188
Abstract

BACKGROUND

Pain is a common symptom of neuromyelitis optica spectrum disorder (NMOSD), but there are relatively few studies on NMOSD pain.

METHODS

We retrospectively reviewed the medical records of 145 patients with NMOSD admitted to our hospital between July 2016 and June 2019.

RESULTS

The clinical characteristics of pain and factors related to NMOSD were analyzed, revealing that the incidence of pain in NMOSD is high and can be used for disease localization.

CONCLUSION

Different types of pain occur at different stages of the disease, and serum aquaporin-4 antibody (AQP4-ab) positivity is an independent risk factor for NMOSD pain. Hormones and biological immune agents may also be effective in some cases.

摘要

背景

疼痛是视神经脊髓炎谱系障碍(NMOSD)的常见症状,但关于NMOSD疼痛的研究相对较少。

方法

我们回顾性分析了2016年7月至2019年6月期间我院收治的145例NMOSD患者的病历。

结果

分析了疼痛的临床特征及与NMOSD相关的因素,发现NMOSD疼痛发生率高且可用于疾病定位。

结论

不同类型的疼痛发生于疾病的不同阶段,血清水通道蛋白4抗体(AQP4-ab)阳性是NMOSD疼痛的独立危险因素。激素和生物免疫制剂在某些情况下可能也有效。

相似文献

1
Pain in neuromyelitis optic spectrum disorder.视神经脊髓炎谱系障碍中的疼痛
Mult Scler Relat Disord. 2022 Dec;68:104192. doi: 10.1016/j.msard.2022.104192. Epub 2022 Sep 23.
2
The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study.视神经脊髓炎谱系疾病中神经病理性疼痛的危险因素:一项回顾性病例队列研究。
BMC Neurol. 2022 Aug 19;22(1):304. doi: 10.1186/s12883-022-02841-9.
3
The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study.视神经脊髓炎谱系障碍中aquaporin-4抗体状态与视路完整性的关系:一项视觉诱发电位研究。
Mult Scler Relat Disord. 2020 Sep;44:102265. doi: 10.1016/j.msard.2020.102265. Epub 2020 Jun 6.
4
Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort.秘鲁队列中视神经脊髓炎谱系障碍的临床和副临床特征
Mult Scler Relat Disord. 2022 Aug;64:103919. doi: 10.1016/j.msard.2022.103919. Epub 2022 May 29.
5
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.韩国多中心回顾性研究:晚发性视神经脊髓炎谱系疾病的临床特征。
Mult Scler. 2017 Nov;23(13):1748-1756. doi: 10.1177/1352458516685416. Epub 2017 Jan 6.
6
Late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies.迟发性视神经脊髓炎谱系疾病伴抗水通道蛋白 4 和抗髓鞘少突胶质细胞糖蛋白抗体。
Eur J Neurol. 2022 Apr;29(4):1128-1135. doi: 10.1111/ene.15239. Epub 2022 Jan 14.
7
[The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].水通道蛋白4抗体在视神经脊髓炎谱系障碍视网膜微观结构损伤中的作用
Zhonghua Nei Ke Za Zhi. 2018 Jun 1;57(6):435-439. doi: 10.3760/cma.j.issn.0578-1426.2018.06.008.
8
Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.在澳大利亚西部对可能患有视神经脊髓炎谱系障碍的患者进行诊断的队列中,抗水通道蛋白 4 抗体的流行情况。
J Neuroimmunol. 2018 Nov 15;324:76-80. doi: 10.1016/j.jneuroim.2018.09.006. Epub 2018 Sep 14.
9
Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.抗Ro/SSA抗体的存在可能与视神经脊髓炎谱系障碍中抗水通道蛋白4抗体阳性有关。
J Neurol Sci. 2015 Jan 15;348(1-2):132-5. doi: 10.1016/j.jns.2014.11.020. Epub 2014 Nov 20.
10
Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.水通道蛋白-4 抗体检测在视神经脊髓炎谱系疾病患者中的应用。
Mult Scler. 2013 Jul;19(8):1060-7. doi: 10.1177/1352458512472748. Epub 2013 Jan 17.

引用本文的文献

1
Effective Control of Neuropathic Pain With Amitriptyline in Neuromyelitis Optica Spectrum Disorder: A Case Report.阿米替林有效控制视神经脊髓炎谱系障碍中的神经性疼痛:一例报告
Cureus. 2025 Jul 9;17(7):e87639. doi: 10.7759/cureus.87639. eCollection 2025 Jul.
2
The association between vision impairment and multi-site pain in middle-aged and older adults in China: results from the China health and retirement longitudinal study.中国中老年人群视力障碍与多部位疼痛之间的关联:来自中国健康与养老追踪调查的结果
Front Public Health. 2025 Jun 16;13:1579774. doi: 10.3389/fpubh.2025.1579774. eCollection 2025.
3
Characteristics of pain in patients with NMOSD and MOGAD: impact on mental health, sleep and quality of life.
视神经脊髓炎谱系障碍(NMOSD)和髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)患者的疼痛特征:对心理健康、睡眠和生活质量的影响。
Neurol Sci. 2025 Jun 7. doi: 10.1007/s10072-025-08277-6.
4
Exploring core symptoms and symptom clusters among patients with neuromyelitis optica spectrum disorder: A network analysis.视神经脊髓炎谱系障碍患者核心症状及症状簇的探索:一项网络分析
Int J Nurs Sci. 2025 Feb 15;12(2):152-160. doi: 10.1016/j.ijnss.2025.02.006. eCollection 2025 Mar.